Publications by authors named "Patrick Waller"

Claim this Profile
D
Diagnostic patenting since Myriad: an update.
Patrick R H Waller, Daniel W Young

MLO Med Lab Obs· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a novel regulatory pharmacovigilance prioritisation system: an evaluation of its performance at the UK Medicines and Healthcare products Regulatory Agency.
Suzie Seabroke, Lesley Wise, Patrick Waller

Drug Saf· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
After the Myriad decision: do hurdles remain for diagnostics competition?
Patrick R H Waller, Daniel W Young

MLO Med Lab Obs· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mediator: who's to blame?
Patrick Waller, Stephen Evans

Lancet· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Getting to grips with the new European Union pharmacovigilance legislation.
Patrick Waller

Pharmacoepidemiol Drug Saf· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carbocisteine for acute exacerbations of COPD.
Patrick Waller, Samy Suissa

Lancet· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing tools for the safety specification in risk management plans: lessons learned from a pilot project.
Andrew J P Cooper, Sally Lettis, Charlotte L Chapman, Stephen J W Evans, Patrick C Waller

Pharmacoepidemiol Drug Saf· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European commission consultation on pharmacovigilance.
Patrick Waller, Keith Beard, Toine Egberts, Stephen Evans, Jesper Hallas

Pharmacoepidemiol Drug Saf· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An analysis of the exclusion criteria used in observational pharmacoepidemiological studies.
Michael Perrio, Patrick C Waller, Saad A W Shakir

Pharmacoepidemiol Drug Saf· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Making the most of spontaneous adverse drug reaction reporting.
Patrick C Waller

Basic Clin Pharmacol Toxicol· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug safety and the media.
Patrick C Waller, Stephen J W Evans, Keith Beard

Br J Clin Pharmacol· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of hospital episodes with 'drug-induced' disorders and spontaneously reported adverse drug reactions.
Paul Barrow, Patrick Waller, Lesley Wise

Br J Clin Pharmacol· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact analysis of signals detected from spontaneous adverse drug reaction reporting data.
Patrick Waller, Emma Heeley, Jane Moseley

Drug Saf· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Testing and implementing signal impact analysis in a regulatory setting: results of a pilot study.
Emma Heeley, Patrick Waller, Jane Moseley

Drug Saf· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug safety and regulation.
Patrick C Waller, Stephen J W Evans, Keith Beard

BMJ· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hospital admissions for 'drug-induced' disorders in England: a study using the Hospital Episodes Statistics (HES) database.
Patrick Waller, Mary Shaw, Davidson Ho, Saad Shakir, Shah Ebrahim

Br J Clin Pharmacol· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The reporting odds ratio versus the proportional reporting ratio: 'deuce'.
Patrick Waller, Eugène van Puijenbroek, Antoine Egberts, Stephen Evans

Pharmacoepidemiol Drug Saf· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is aspirin a cause of Reye's syndrome?
Patrick Waller, Rafe Suvarna

Drug Saf· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A model for the future conduct of pharmacovigilance.
Patrick C Waller, Stephen J W Evans

Pharmacoepidemiol Drug Saf· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dealing with uncertainty in drug safety: lessons for the future from sertindole.
Patrick Waller

Pharmacoepidemiol Drug Saf· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis